Dimethylheptyl-THC-11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure

Arthritis and Rheumatism

Volumn 41, Issue 1, 1998, Pages 163-170

  Zurier, Robert B ^a   Rossetti, Ronald G ^a   Lane, Joan H ^b   Goldberg, John M ^a   Hunter, Sheila A ^a   Burstein, Sumner H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b TSI Mason Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIMETHYLHEPTYLTETRAHYDOCANNABINOL 11 OIC ACID; ICOSANOID; INTERLEUKIN 1BETA; SAFFLOWER OIL; TETRAHYDROCANNABINOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG SCREENING; FEMALE; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANNUS; PRIORITY JOURNAL; RAT; SHEEP; SKIN INFLAMMATION; TREATMENT OUTCOME;

3T3 CELLS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CHRONIC DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EICOSANOIDS; FEMALE; FREUND'S ADJUVANT; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED LEW; SKIN; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031962165     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9     Document Type: Article

References (27)

1. Hui-Lin L. The origin and use of cannabis in Eastern Asia. In: Rubin V, editor. Cannabis and culture. The Hague: Mouton; 1975. p. 51-62.
2. 1-tetrahydrocannabinol. Science 1972;176:422-4.
3. Perez-Reyes M. Pharmacodynamics of certain drugs of abuse. In: Barnett G, Chiang NC, editors. Pharmacokinetics and pharmaco-dynamics of psychoactive drugs. Foster City (CA): Biomedical Publishers; 1985. p. 287-310.
4. Burstein SH, Hull K, Hunter SA, Latham V. Cannabinoids and pain responses: a possible role for prostaglandins. FASEB J 1988;2:3022-6.
5. 6-THC-7-oic acid. Agents Actions 1990;31:157-62.
6. Burstein SH, Audette CA, Doyle SA, Hull K, Hunter SA, Latham V. Antagonism to the actions of PAF by a non psychoactive cannabinoid. J Pharmacol Exp Ther 1989;251:531-5.
7. 1-THC action by its metabolites. Biochem Pharmacol 1986;35:2553-8.
8. Loev B, Bender PE, Dowalo F, Macko E, Fowler PJ. Cannabinoids: structure-activity studies related to 1,2-dimethylheptyl derivatives. J Med Chem 1973;16:1200-6.
9. Burstein SH, Audette CA, Breuer A, Devane WA, Colodner S, Doyle SA, et al. Synthetic non psychotropic cannabinoids with potent antiinflammatory, analgesic and leukocyte antiadhesion activities. J Med Chem 1992;35:3135-41.
10. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
11. Taurog JD, Argentieri DC, Reynolds RA. Adjuvant arthritis. Methods Enzymol 1988;162:339-55.
12. Rossetti RG, Seiler CM, Brathwaite K, Zurier RB. Effect of misoprosotol on acute and chronic inflammation. Am J Ther 1995;2:600-6.
13. Glenn E, Gray J. Adjuvant induced polyarthritis in rats: biologic and histologic background. Am J Vet Res 1964;26:1180-94.
14. Pearson CM, Wood FD. Studies of arthritis and other lesions induced in rats by the injection of mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis. Am J Pathol 1963;42:73-95.
15. Kujubu DA, Fletcher S, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells encodes a novel prostaglandin synthetase/ cyclooxygenase homologue. J Biol Chem 1981;266:12866-72.
16. Kujubu DA, Herschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J Biol Chem 1992;267:7991-4.
17. Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 1996;16:181-6.
18. Edwards JC, Sedgwick AD, Willoughby DA. The formation of a structure with the features of synovial lining by subcutaneous injections of air: an in vivo tissue culture system. J Pathol 1981;134:147-56.
19. Esser RE, Eyerman MC, Port CD, Anderson W. Proinflammatory effects of interleukin-1 in the rat air pouch. Int J Tissue React 1989;XI:291-300.
20. Audette CA, Burstein S. Inhibition of leukocyte adhesion by the in vivo and in vitro administration of cannabinoids. Life Sci 1990;47:753-9.
21. Brinckerhoff CE. Joint destruction in arthritis: metalloproteinases in the spotlight. Arthritis Rheum 1991;34:1073-5.
22. Pelegri C, Franch A, Castellote C, Castell M. Immunohistochemical changes in synovial tissue during the course of adjuvant arthritis. J Rheumatol 1995;22:124-32.
23. Clark KSD, Kobayashi DK, Welgus HG. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 1987;80:1280-8.
24. Frisch SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 1987;262:16300-4.
25. Arias-Negrete S, Keller K, Chandee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 1995;208:582-9.
26. DeWitt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1991;1083:121-34.
27. 1-THC-7-oic acid and analgesic and antiinflammatory agents. US Patent 4,847,290. July 1989.